BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22684055)

  • 1. Structure of human ADAM-8 catalytic domain complexed with batimastat.
    Hall T; Shieh HS; Day JE; Caspers N; Chrencik JE; Williams JM; Pegg LE; Pauley AM; Moon AF; Krahn JM; Fischer DH; Kiefer JR; Tomasselli AG; Zack MD
    Acta Crystallogr Sect F Struct Biol Cryst Commun; 2012 Jun; 68(Pt 6):616-21. PubMed ID: 22684055
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Substrate specificity determinants of human macrophage elastase (MMP-12) based on the 1.1 A crystal structure.
    Lang R; Kocourek A; Braun M; Tschesche H; Huber R; Bode W; Maskos K
    J Mol Biol; 2001 Sep; 312(4):731-42. PubMed ID: 11575928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 1.8-A crystal structure of the catalytic domain of human neutrophil collagenase (matrix metalloproteinase-8) complexed with a peptidomimetic hydroxamate primed-side inhibitor with a distinct selectivity profile.
    Betz M; Huxley P; Davies SJ; Mushtaq Y; Pieper M; Tschesche H; Bode W; Gomis-Rüth FX
    Eur J Biochem; 1997 Jul; 247(1):356-63. PubMed ID: 9249047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structure determination and analysis of human neutrophil collagenase complexed with a hydroxamate inhibitor.
    Grams F; Crimmin M; Hinnes L; Huxley P; Pieper M; Tschesche H; Bode W
    Biochemistry; 1995 Oct; 34(43):14012-20. PubMed ID: 7577999
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Batimastat, a potent matrix mealloproteinase inhibitor, exhibits an unexpected mode of binding.
    Botos I; Scapozza L; Zhang D; Liotta LA; Meyer EF
    Proc Natl Acad Sci U S A; 1996 Apr; 93(7):2749-54. PubMed ID: 8610113
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystal structure of the catalytic domain of MMP-16/MT3-MMP: characterization of MT-MMP specific features.
    Lang R; Braun M; Sounni NE; Noel A; Frankenne F; Foidart JM; Bode W; Maskos K
    J Mol Biol; 2004 Feb; 336(1):213-25. PubMed ID: 14741217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fluorescent Analogue of Batimastat Enables Imaging of α-Secretase in Living Cells.
    Leriche G; Chen AC; Kim S; Selkoe DJ; Yang J
    ACS Chem Neurosci; 2016 Jan; 7(1):40-5. PubMed ID: 26559179
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling of enzyme-substrate complexes for the metalloproteases MMP-3, ADAM-9 and ADAM-10.
    Manzetti S; McCulloch DR; Herington AC; van der Spoel D
    J Comput Aided Mol Des; 2003 Sep; 17(9):551-65. PubMed ID: 14713188
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhibition of membrane-type 1 matrix metalloproteinase by hydroxamate inhibitors: an examination of the subsite pocket.
    Yamamoto M; Tsujishita H; Hori N; Ohishi Y; Inoue S; Ikeda S; Okada Y
    J Med Chem; 1998 Apr; 41(8):1209-17. PubMed ID: 9548812
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The design, synthesis, and structure-activity relationships of a series of macrocyclic MMP inhibitors.
    Steinman DH; Curtin ML; Garland RB; Davidsen SK; Heyman HR; Holms JH; Albert DH; Magoc TJ; Nagy IB; Marcotte PA; Li J; Morgan DW; Hutchins C; Summers JB
    Bioorg Med Chem Lett; 1998 Aug; 8(16):2087-92. PubMed ID: 9873491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High-resolution solution structure of the catalytic fragment of human collagenase-3 (MMP-13) complexed with a hydroxamic acid inhibitor.
    Moy FJ; Chanda PK; Chen JM; Cosmi S; Edris W; Levin JI; Powers R
    J Mol Biol; 2000 Sep; 302(3):671-89. PubMed ID: 10986126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Solution structure and backbone dynamics of the catalytic domain of matrix metalloproteinase-2 complexed with a hydroxamic acid inhibitor.
    Feng Y; Likos JJ; Zhu L; Woodward H; Munie G; McDonald JJ; Stevens AM; Howard CP; De Crescenzo GA; Welsch D; Shieh HS; Stallings WC
    Biochim Biophys Acta; 2002 Jul; 1598(1-2):10-23. PubMed ID: 12147339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High resolution crystal structure of the catalytic domain of ADAMTS-5 (aggrecanase-2).
    Shieh HS; Mathis KJ; Williams JM; Hills RL; Wiese JF; Benson TE; Kiefer JR; Marino MH; Carroll JN; Leone JW; Malfait AM; Arner EC; Tortorella MD; Tomasselli A
    J Biol Chem; 2008 Jan; 283(3):1501-1507. PubMed ID: 17991750
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate specificity of a metalloprotease of the pappalysin family revealed by an inhibitor and a product complex.
    García-Castellanos R; Tallant C; Marrero A; Solà M; Baumann U; Gomis-Rüth FX
    Arch Biochem Biophys; 2007 Jan; 457(1):57-72. PubMed ID: 17097044
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selective inhibition of low affinity IgE receptor (CD23) processing.
    Bailey S; Bolognese B; Buckle DR; Faller A; Jackson S; Louis-Flamberg P; McCord M; Mayer RJ; Marshall LA; Smith DG
    Bioorg Med Chem Lett; 1998 Jan; 8(1):29-34. PubMed ID: 9871623
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Crystal structure of human macrophage elastase (MMP-12) in complex with a hydroxamic acid inhibitor.
    Nar H; Werle K; Bauer MM; Dollinger H; Jung B
    J Mol Biol; 2001 Sep; 312(4):743-51. PubMed ID: 11575929
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression and protein chemistry yielding crystallization of the catalytic domain of ADAM17 complexed with a hydroxamate inhibitor.
    Hoth LR; Tan DH; Wang IK; Wengender PA; Thompson MA; Kamath AV; Geoghegan KF
    Protein Expr Purif; 2007 Apr; 52(2):313-9. PubMed ID: 17169570
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystal structures of human ADAMTS-1 reveal a conserved catalytic domain and a disintegrin-like domain with a fold homologous to cysteine-rich domains.
    Gerhardt S; Hassall G; Hawtin P; McCall E; Flavell L; Minshull C; Hargreaves D; Ting A; Pauptit RA; Parker AE; Abbott WM
    J Mol Biol; 2007 Nov; 373(4):891-902. PubMed ID: 17897672
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extra binding region induced by non-zinc chelating inhibitors into the S1' subsite of matrix metalloproteinase 8 (MMP-8).
    Pochetti G; Montanari R; Gege C; Chevrier C; Taveras AG; Mazza F
    J Med Chem; 2009 Feb; 52(4):1040-9. PubMed ID: 19173605
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct roles for ADAM10 and ADAM17 in ectodomain shedding of six EGFR ligands.
    Sahin U; Weskamp G; Kelly K; Zhou HM; Higashiyama S; Peschon J; Hartmann D; Saftig P; Blobel CP
    J Cell Biol; 2004 Mar; 164(5):769-79. PubMed ID: 14993236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.